Your question is Oncology Drug Market Entry. Take a moment with it on the right.
Talk me through your thinking if you like. When you're confident, submit your answer and I'll grade it like a real screen (7/10 or better passes).
How would you assess the market entry strategy for a new oncology drug in the European market?